Formación de equimosis y/o hematoma tras la administración profiláctica de enoxaparina subcutánea en abdomen o brazo en pacientes críticos

Enfermería Intensiva - Tập 29 - Trang 4-13 - 2018
R. Jareño-Collado1, M.M. Sánchez-Sánchez1, M.P. Fraile-Gamo1, N. García-Crespo1, S. Barba-Aragón1, H. Bermejo-García1, R. Sánchez-Izquierdo1, E.I. Sánchez-Muñoz1, A. López-López1, S. Arias-Rivera2
1Servicio de Cuidados Intensivos, Hospital Universitario de Getafe, Getafe, Madrid, España
2Hospital Universitario de Getafe, CIBER Enfermedades Respiratorias, Instituto de Salud Carlos III, Getafe, Madrid, España

Tài liệu tham khảo

Gray, 2008, Heparin and low-molecular-weight heparin, NIBCS, J Thromb Haemost., 99, 807, 10.1160/TH08-01-0032 Wallentin, 1996, Low molecular weight heparins: A valuable tool in the treatment of acute coronary syndromes, Eur Heart J., 17, 1470, 10.1093/oxfordjournals.eurheartj.a014708 Boneu, 1994, Low molecular weight heparin therapy: Is monitoring needed?, Thromb Haemost., 72, 330, 10.1055/s-0038-1648866 Gupta, 1995, Seven steps for administering enoxaparin, Nursing., 25, 72, 10.1097/00152193-199509000-00027 Agencia Española de Medicamentos y Productos Sanitarios. Madrid [consultado 4 Jun 2014]. Ficha Técnica de Clexane. Disponible en: https://www.aemps.gob.es/cima/pdfs/es/ft/62472/FT_62472.pdf Laposata, 1998, College of American Pathologists Conference XXXI on laboratory monitoring of anticoagulant therapy: The clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban, Arch Pathol Lab Med., 122, 799 Vademécum Farmacéutico IPE On-Line. México [consultado 1 Ago 2013]. Clexane. Solución inyectable. Disponible en: http://www.medicamentos.com.mx/dochtm/15949.htm Aguilera-Manrique, 2002, Administración de heparinas de bajo peso molecular y aparición de hematoma, Enferm Clin., 12, 89, 10.1016/S1130-8621(02)73735-2 Hunter, 2008, Subcutaneous injection technique, Nurs Stand., 22, 41 Gómez, 2005, ¿Cuál es la técnica idónea para disminuir las complicaciones locales secundarias a la administración subcutánea de enoxaparina? Ensayo clínico aleatorizado, Enferm Clin., 15, 329, 10.1016/S1130-8621(05)71139-6 Zaybak, 2008, A study on the effect of the duration of subcutaneous heparin injection on bruising and pain, J Clin Nurs., 17, 378 Garrido-Díaz Malaguilla, 1996, Heparinas de bajo peso molecular. Cambios en la técnica de administración, Rev ROL Enferm., 217, 55 Vanbree, 1984, Clinical evaluation of three techniques for administering low-dose heparin, Nurs Res., 33, 15, 10.1097/00006199-198401000-00004 Coley, 1987, Effect of needle size on pain and hematoma formation with subcutaneous injection of heparin sodium, Clin Pharm., 6, 725 Brenner, 1980, Effects of alternative techniques of low-dose heparin administration on hematoma formation, Hearth Lung., 10, 657 Akpinar, 2008, Effect of injection duration on bruising associated with subcutaneous heparin: A quasi-experimental within-subject design, Int J Nurs Stud., 45, 812, 10.1016/j.ijnurstu.2007.02.005 Pourghaznein, 2014, The effect of injection duration and injection site on pain and bruising of subcutaneous injection of heparin, J Clin Nurs., 23, 1105, 10.1111/jocn.12291 Wooldridge, 1988, Evaluation of bruises and areas or induration after two techniques of subcutaneous heparin injection, Heart Lung., 17, 476 Fahs, 1991, The abdomen, thigh and arm as sites for subcutaneous sodium heparin injections, Nurs Res., 40, 204 Chan, 2001, Effects of injection duration on site pain intensity and bruising associated with subcutaneous heparin, J Adv Nurs., 35, 882, 10.1046/j.1365-2648.2001.01925.x Palese, 2013, Ocurrence and extent of bruising according to duration of administration of subcutaneous low-molecular-weight heparin: A quasi-experimental case-crossover study, J Cardiovasc Nurs., 28, 473, 10.1097/JCN.0b013e3182578b87 Avşar, 2013, Assessment of four different methods in subcutaneous heparin applications with regard to causing bruise and pain, Int J Nurs Pract., 19, 402, 10.1111/ijn.12079 Kuzu, 2001, The effect of cold on the occurrence of bruising, haematoma and pain at the injection site in subcutaneous low molecular weight heparin, Int J Nurs Stud., 38, 51, 10.1016/S0020-7489(00)00061-4 Ondrugdelivery. East Sussex. Inglaterra [consultado 1 Ago 2013]. Prefillled Syringes: innovations that meet the growing demand. Disponible en: http://www.ondrugdelivery.com/publications/prefilled_syringes.pdf Akbari Sari, 2014, Slow versus fast subcutaneous heparin injections for prevention of bruising and site-pain intensity, Cochrane Database Syst Rev., 18, 10.1002/14651858.CD008077.pub3 Nagle, 1998, Low molecular weight heparin enoxaparin, RN, 61, 40 Rushing, 2008, Administering an enoxaparin injection, Nursing., 38, 19, 10.1097/01.NURSE.0000312604.60149.84 McConnell, 2000, Do's and don’ts: Administering subcutaneous heparin, Nursing., 30, 17 Annersten, 2005, Performing subcutaneous injections: A literature review, Worldviews Evid Based Nurs., 2, 122, 10.1111/j.1741-6787.2005.00030.x Declaración de Helsinki de la AMM - Principios éticos para las investigaciones médicas en seres humanos [consultado 27 Abr 2017]. Disponible en: http://www.isciii.es/ISCIII/es/contenidos/fd-investigacion/fd-evaluacion/fd-evaluacion-etica-investigacion/Declaracion-Helsinki-2013-Esp.pdf